AAAAAA

   
Results: 1-23 |
Results: 23
DEFINITIONS AND BASIC REQUIREMENTS FOR THE USE OF TERMS FOR REPORTINGADVERSE DRUG-REACTIONS (X) - GASTROINTESTINAL SYSTEM DISORDERS
Authors: AELLIG W BADER JP BASS R BAUMBAUER E BEGLINGER C BRUPPACHER R CARLHANTKOWALSKI D CRUSIUS I GALLAGHER J GALLOTORRES H GELLERT J HULLA F KREMER G KREUTZ G LAMACHE E MANN RD PFEIFFER M REITER C RHODES JM SCHRANK J STEINBACH T VENULET J VILARDELL F
Citation: W. Aellig et al., DEFINITIONS AND BASIC REQUIREMENTS FOR THE USE OF TERMS FOR REPORTINGADVERSE DRUG-REACTIONS (X) - GASTROINTESTINAL SYSTEM DISORDERS, Pharmacoepidemiology and drug safety, 7(4), 1998, pp. 281-287
PARKINSONS-DISEASE AND DEPRESSION
Authors: BADER JP HELL D
Citation: Jp. Bader et D. Hell, PARKINSONS-DISEASE AND DEPRESSION, Fortschritte der Neurologie, Psychiatrie, 66(7), 1998, pp. 303-312
AZODICARBONAMIDE INHIBITS HIV-1 REPLICATION BY TARGETING THE NUCLEOCAPSID PROTEIN
Authors: RICE WG TURPIN JA HUANG MJ CLANTON D BUCKHEIT RW COVELL DG WALLQVIST A MCDONNELL NB DEGUZMAN RN SUMMERS MF ZALKOW L BADER JP HAUGWITZ RD SAUSVILLE EA
Citation: Wg. Rice et al., AZODICARBONAMIDE INHIBITS HIV-1 REPLICATION BY TARGETING THE NUCLEOCAPSID PROTEIN, Nature medicine, 3(3), 1997, pp. 341-345
A NEW CLASS OF ANTI-HIV-1 AGENTS TARGETED TOWARD THE NUCLEOCAPSID PROTEIN NCP7 - THE 2,2'-DITHIOBISBENZAMIDES
Authors: DOMAGALA JM BADER JP GOGLIOTTI RD SANCHEZ JP STIER MA SONG YT PRASAD JVNV TUMMINO PJ SCHOLTEN J HARVEY P HOLLER T GRACHECK S HUPE D RICE WG SCHULTZ R
Citation: Jm. Domagala et al., A NEW CLASS OF ANTI-HIV-1 AGENTS TARGETED TOWARD THE NUCLEOCAPSID PROTEIN NCP7 - THE 2,2'-DITHIOBISBENZAMIDES, Bioorganic & medicinal chemistry, 5(3), 1997, pp. 569-579
2'-FLUORO-2',3'-DIDEOXYARABINOSYLADENINE (F-DDA) - ACTIVITY AGAINST DRUG-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS STRAINS AND CLADES A-E
Authors: DRISCOLL JS MAYERS DL BADER JP WEISLOW OS JOHNS DG BUCKHEIT RW
Citation: Js. Driscoll et al., 2'-FLUORO-2',3'-DIDEOXYARABINOSYLADENINE (F-DDA) - ACTIVITY AGAINST DRUG-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS STRAINS AND CLADES A-E, Antiviral chemistry & chemotherapy, 8(2), 1997, pp. 107-111
EFFICACY, PHARMACOKINETICS, AND IN-VIVO ANTIVIRAL ACTIVITY OF UC781, A HIGHLY POTENT, ORALLY BIOAVAILABLE NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR OF HIV TYPE-1
Authors: BUCKHEIT RW HOLLINGSHEAD M SINSON S FLIAKASBOLTZ V PALLANSCH LA ROBERSON J DECKER W ELDER C BORGEL S BONOMI C SHORES R SIFORD T MALSPEIS L BADER JP
Citation: Rw. Buckheit et al., EFFICACY, PHARMACOKINETICS, AND IN-VIVO ANTIVIRAL ACTIVITY OF UC781, A HIGHLY POTENT, ORALLY BIOAVAILABLE NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR OF HIV TYPE-1, AIDS research and human retroviruses, 13(9), 1997, pp. 789-796
INHIBITION OF MULTIPLE PHASES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION BY A DITHIANE COMPOUND THAT ATTACKS THE CONSERVED ZINC FINGERS OF RETROVIRAL NUCLEOCAPSID PROTEINS
Authors: RICE WG BAKER DC SCHAEFFER CA GRAHAM L BU M TERPENING S CLANTON D SCHULTZ R BADER JP BUCKHEIT RW FIELD L SINGH PK TURPIN JA
Citation: Wg. Rice et al., INHIBITION OF MULTIPLE PHASES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION BY A DITHIANE COMPOUND THAT ATTACKS THE CONSERVED ZINC FINGERS OF RETROVIRAL NUCLEOCAPSID PROTEINS, Antimicrobial agents and chemotherapy, 41(2), 1997, pp. 419-426
A DIARYLSULPHONE NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR WITH AUNIQUE SENSITIVITY PROFILE TO DRUG-RESISTANT VIRUS ISOLATES
Authors: BUCKHEIT RW FLIAKASBOLTZ V RUSSELL JD SNOW M PALLANSCH LA YANG SS BADER JP KHAN TN ZANGER M
Citation: Rw. Buckheit et al., A DIARYLSULPHONE NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR WITH AUNIQUE SENSITIVITY PROFILE TO DRUG-RESISTANT VIRUS ISOLATES, Antiviral chemistry & chemotherapy, 7(5), 1996, pp. 243-252
INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION BY THE SULFONATED STILBENE DYE RESOBENE
Authors: HALLIDAY SM LACKMANSMITH C BADER JP RICE WG CLANTON DJ ZALKOW LH BUCKHEIT RW
Citation: Sm. Halliday et al., INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION BY THE SULFONATED STILBENE DYE RESOBENE, Antiviral research, 33(1), 1996, pp. 41-53
BIOLOGICAL AND BIOCHEMICAL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITYOF UC-38, A NEW NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR
Authors: MCMAHON JB BUCKHEIT RW GULAKOWSKI RJ CURRENS MJ VISTICA DT SHOEMAKER RH STINSON SF RUSSELL JD BADER JP NARAYANAN VL SCHULTZ RJ BROUWER WG FELAUER EE BOYD MR
Citation: Jb. Mcmahon et al., BIOLOGICAL AND BIOCHEMICAL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITYOF UC-38, A NEW NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, The Journal of pharmacology and experimental therapeutics, 276(1), 1996, pp. 298-305
MASS-SCREENING FOR COLORECTAL-CANCER - STATEMENT OF THE EUROPEAN GROUP FOR COLORECTAL-CANCER SCREENING
Authors: FAIVRE J BADER JP BERTARIO L BESBEAS S CASTIGLIONE G CHAMBERLAIN J DUBOIS G FRIC P GNAUCK R HARDCASTLE J KEWENTER J KRONBORG O MALTONI G WAHRENDORF J
Citation: J. Faivre et al., MASS-SCREENING FOR COLORECTAL-CANCER - STATEMENT OF THE EUROPEAN GROUP FOR COLORECTAL-CANCER SCREENING, European journal of cancer prevention, 4(5), 1995, pp. 437-439
NOVEL INHIBITORS OF RETROVIRAL NUCLEOCAPSID PROTEIN ZINC FINGERS AS CANDIDATES FOR THE TREATMENT OF HIV-1 INFECTION
Authors: RICE WG TURPIN JA DOMAGALA J BADER JP ARTHUR LO HENDERSON LE
Citation: Wg. Rice et al., NOVEL INHIBITORS OF RETROVIRAL NUCLEOCAPSID PROTEIN ZINC FINGERS AS CANDIDATES FOR THE TREATMENT OF HIV-1 INFECTION, AIDS research and human retroviruses, 11, 1995, pp. 161-161
CHARACTERISTICS OF A GROUP OF NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS WITH STRUCTURAL DIVERSITY AND POTENT ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITY
Authors: YANG SS FLIAKASBOLTZ V BADER JP BUCKHEIT RW
Citation: Ss. Yang et al., CHARACTERISTICS OF A GROUP OF NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS WITH STRUCTURAL DIVERSITY AND POTENT ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITY, Leukemia, 9, 1995, pp. 75-85
NOVEL SULFONATED AND PHOSPHONATED ANALOGS OF DISTAMYCIN WHICH INHIBITTHE REPLICATION OF HIV
Authors: CLANTON DJ BUCKHEIT RW TERPENING SJ KISER R MONGELLI N BORGIA AL SCHULTZ R NARAYANAN V BADER JP RICE WG
Citation: Dj. Clanton et al., NOVEL SULFONATED AND PHOSPHONATED ANALOGS OF DISTAMYCIN WHICH INHIBITTHE REPLICATION OF HIV, Antiviral research, 27(4), 1995, pp. 335-354
COMPARITIVE ANTI-HIV EVALUATION OF DIVERSE HIV-1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITOR-RESISTANT VIRUS ISOLATES DEMONSTRATES THE EXISTENCE OF DISTINCT PHENOTYPIC SUBGROUPS
Authors: BUCKHEIT RW FLIAKASBOLTZ V DECKER WD ROBERSON JL STUP TL PYLE CA WHITE EL MCMAHON JB CURRENS MJ BOYD MR BADER JP
Citation: Rw. Buckheit et al., COMPARITIVE ANTI-HIV EVALUATION OF DIVERSE HIV-1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITOR-RESISTANT VIRUS ISOLATES DEMONSTRATES THE EXISTENCE OF DISTINCT PHENOTYPIC SUBGROUPS, Antiviral research, 26(2), 1995, pp. 117-132
STRUCTURE-ACTIVITY AND CROSS-RESISTANCE EVALUATIONS OF A SERIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SPECIFIC COMPOUNDS RELATED TO OXATHIIN CARBOXANILIDE
Authors: BUCKHEIT RW KINJERSKI TL FLIAKASBOLTZ V RUSSELL JD STUP TL PALLANSCH LA BROUWER WG DAO DC HARRISON WA SCHULTZ RJ BADER JP YANG SS
Citation: Rw. Buckheit et al., STRUCTURE-ACTIVITY AND CROSS-RESISTANCE EVALUATIONS OF A SERIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SPECIFIC COMPOUNDS RELATED TO OXATHIIN CARBOXANILIDE, Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2718-2727
RESISTANCE TO 1-[(2-HYDROXYETHOXY)METHYL]-6-(PHENYLTHIO)THYMINE DERIVATIVES IS GENERATED BY MUTATIONS AT MULTIPLE SITES IN THE HIV-1 REVERSE-TRANSCRIPTASE
Authors: BUCKHEIT RW FLIAKASBOLTZ V YEAGYBARGO S WEISLOW O MAYERS DL BOYER PL HUGHES SH PAN BC CHU SH BADER JP
Citation: Rw. Buckheit et al., RESISTANCE TO 1-[(2-HYDROXYETHOXY)METHYL]-6-(PHENYLTHIO)THYMINE DERIVATIVES IS GENERATED BY MUTATIONS AT MULTIPLE SITES IN THE HIV-1 REVERSE-TRANSCRIPTASE, Virology, 210(1), 1995, pp. 186-193
INHIBITORS OF HIV NUCLEOCAPSID PROTEIN ZINC FINGERS AS CANDIDATES FORTHE TREATMENT OF AIDS
Authors: RICE WG SUPKO JG MALSPEIS L BUCKHEIT RW CLANTON D BU M GRAHAM L SCHAEFFER CA TURPIN JA DOMAGALA J GOGLIOTTI R BADER JP HALLIDAY SM COREN L SOWDER RC ARTHUR LO HENDERSON LE
Citation: Wg. Rice et al., INHIBITORS OF HIV NUCLEOCAPSID PROTEIN ZINC FINGERS AS CANDIDATES FORTHE TREATMENT OF AIDS, Science, 270(5239), 1995, pp. 1194-1197
CLINICAL EFFICACY OF PANTOPRAZOLE COMPARED WITH RANITIDINE
Authors: BADER JP DELCHIER JC
Citation: Jp. Bader et Jc. Delchier, CLINICAL EFFICACY OF PANTOPRAZOLE COMPARED WITH RANITIDINE, Alimentary pharmacology & therapeutics, 8, 1994, pp. 47-52
BIOLOGICAL AND BIOCHEMICAL ANTI-HIV ACTIVITY OF THE BENZOTHIADIAZINE CLASS OF NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS
Authors: BUCKHEIT RW FLIAKASBOLTZ V DECKER WD ROBERSON JL PYLE CA WHITE EL BOWDEN BJ MCMAHON JB BOYD MR BADER JP NICKELL DG BARTH H ANTONUCCI TK
Citation: Rw. Buckheit et al., BIOLOGICAL AND BIOCHEMICAL ANTI-HIV ACTIVITY OF THE BENZOTHIADIAZINE CLASS OF NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS, Antiviral research, 25(1), 1994, pp. 43-56
DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF COSALANE, A NOVEL ANTI-HIV AGENT WHICH INHIBITS MULTIPLE FEATURES OF VIRUS REPRODUCTION
Authors: CUSHMAN M GOLEBIEWSKI WM MCMAHON JB BUCKHEIT RW CLANTON DJ WEISLOW O HAUGWITZ RD BADER JP GRAHAM L RICE WG
Citation: M. Cushman et al., DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF COSALANE, A NOVEL ANTI-HIV AGENT WHICH INHIBITS MULTIPLE FEATURES OF VIRUS REPRODUCTION, Journal of medicinal chemistry, 37(19), 1994, pp. 3040-3050
DESIGN AND SYNTHESIS OF COSALANE, A NOVEL ANTI-HIV AGENT
Authors: GOLEBIEWSKI WM BADER JP CUSHMAN M
Citation: Wm. Golebiewski et al., DESIGN AND SYNTHESIS OF COSALANE, A NOVEL ANTI-HIV AGENT, Bioorganic & medicinal chemistry letters, 3(8), 1993, pp. 1739-1742
THIAZOLOBENZIMIDAZOLE - BIOLOGICAL AND BIOCHEMICAL ANTIRETROVIRAL ACTIVITY OF A NEW NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR
Authors: BUCKHEIT RW HOLLINGSHEAD MG GERMANYDECKER J WHITE EL MCMAHON JB ALLEN LB ROSS LJ DECKER WD WESTBROOK L SHANNON WM WEISLOW O BADER JP BOYD MR
Citation: Rw. Buckheit et al., THIAZOLOBENZIMIDAZOLE - BIOLOGICAL AND BIOCHEMICAL ANTIRETROVIRAL ACTIVITY OF A NEW NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, Antiviral research, 21(3), 1993, pp. 247-265
Risultati: 1-23 |